OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
October 28, 2022
The newly formed partnership between CSafe and BioLife will expand cold chain supply chain solutions for the cell and gene therapy market.
October 25, 2022
October 12, 2022
CBER maps modernization plan to handle surge in research and applications.
October 01, 2022
Biopharma focuses on streamlining biomanufacturing and supply chain issues to drive uptake of cell and gene therapies.
September 15, 2022
Document integrity is critical in the provision of raw materials for cell and gene therapy manufacturing.
For cell and gene therapies to reach their full potential, changes in manufacturing must be explored.
September 09, 2022
Charles River Laboratories and Cure AP-4 will collaborate on gene therapy manufacturing for AP-4 hereditary spastic paraplegia.
August 31, 2022
Forecyte Bio and Cytiva will team up to accelerate the development and manufacturing of cell and gene therapies.
August 02, 2022
The growth in demand of viral-vector-based gene therapies drives continuous efforts to improve viral vector manufacturing.
July 13, 2022
Pfizer and Touchlight have signed a patent license agreement for Pfizer to use Touchlight’s doggybone DNA (dbDNA) in the manufacture of mRNA vaccines, therapeutics, and gene therapies.